Bharat Biotech's COVID-19 nasal vaccine phase III trials completed
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine
Source: parisguardian.com